11. STOCKHOLDERS’ DEFICIT |
12 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Equity [Abstract] | |
| 11. STOCKHOLDERS’ DEFICIT | 11. STOCKHOLDERS’ DEFICIT
The Company is authorized to issue 200,000,000 shares of $0.001 par value common stock. The Company had issued 5,403,843 and 5,316,843 and outstanding shares of common stock as of December 31, 2025 and 2024, respectively.
On February 12, 2025, the Company sold 62,000 units consisting of one share of common stock and one two year warrant exercisable at $0.60 for $24,780, of which 25,000 shares sold for $10,000 was received during the year ended December 31, 2024 and was included in stock payable.
On February 12, 2025, the Company issued 25,000 shares of common stock for $10,000, which was received during the year ended December 31, 2024 and was included in stock payable.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|